These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 23608451)
1. What's new in prognostication of melanoma in the dermatopathology laboratory? Bangash HK; Romegialli A; Dadras SS Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451 [TBL] [Abstract][Full Text] [Related]
2. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements. Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744 [TBL] [Abstract][Full Text] [Related]
3. A proposal for improving multicolor FISH sensitivity in the diagnosis of malignant melanoma using new combined criteria. Kerl K; Palmedo G; Wiesner T; Mentzel T; Rütten A; Schärer L; Paredes B; Hantschke M; Kutzner H Am J Dermatopathol; 2012 Aug; 34(6):580-5. PubMed ID: 22668575 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence in-situ hybridization analysis for melanoma diagnosis. Senetta R; Paglierani M; Massi D Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736 [TBL] [Abstract][Full Text] [Related]
5. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064 [TBL] [Abstract][Full Text] [Related]
6. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Gammon B; Beilfuss B; Guitart J; Gerami P Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344 [TBL] [Abstract][Full Text] [Related]
7. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions. Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056 [TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status. Fang Y; Dusza S; Jhanwar S; Busam KJ Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674 [TBL] [Abstract][Full Text] [Related]
9. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. Zembowicz A; Yang SE; Kafanas A; Lyle SR Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100 [TBL] [Abstract][Full Text] [Related]
11. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization for ambiguous melanocytic tumors. Gammon B; Gerami P Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884 [TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases. North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603 [TBL] [Abstract][Full Text] [Related]
14. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens. Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835 [TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma. Gerami P; Geraminegad P G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743 [TBL] [Abstract][Full Text] [Related]